Cerebellar degeneration caused by high‐dose cytosine arabinoside: A clinicopathological study

Annals of Neurology

Volumn 14, Issue 5, 1983, Pages 520-527

  Winkelman, Marc D ^a   Hines, John D ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN;

ADVERSE DRUG REACTION; ATAXIA; AUTOPSY; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; CEREBELLUM DEGENERATION; CHEMOTHERAPY; CLINICAL ARTICLE; DRUG DOSE; DRUG THERAPY; DYSARTHRIA; HISTOLOGY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LYMPHATIC SYSTEM; LYMPHOMA; NERVOUS SYSTEM; NEUROTOXICITY; NYSTAGMUS; PURKINJE CELL; THERAPY; VISUAL SYSTEM;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CEREBELLAR ATAXIA; CEREBELLAR CORTEX; CEREBELLAR NUCLEI; CEREBELLUM; CYTARABINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE MOVEMENTS; FEMALE; HUMAN; LEUKEMIA; MALE; MIDDLE AGE; NERVE DEGENERATION; NYSTAGMUS, PATHOLOGIC; PURKINJE CELLS;

EID: 0021030155     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410140505     Document Type: Article

References (47)

1. The effects of systemic hypotension upon the human brain: clinical and neuropathological observations in 11 cases
2. Nutritional cerebellar degeneration
3. A comparison of the effects of cytosine arabinoside and adenine arabinoside on some aspects of brain growth and development in the rat
4. Effect of the antiviral drug, cytosine arabinoside, on the developing nervous system
5. Intrathecal methotrexate
6. Oculomotor disturbances associated with 5‐fluorouracil chemotherapy
7. Paraparesis following intrathecal cytosine arabinoside
8. Cerebral hypoxia
9. Low level incorporation of tritiated thymidine into the nuclear DNA of Purkinje neurons of adult mice
10. An analysis of the mechanism and a study of the morbid anatomy of neurological disorders incident to operations on the neck and thorax
11. High dose Ara‐C with sequential asparaginase for remission induction in acute leukemia (abstract)
12. The mechanisms of lethal action of arabinosyl cytosine and arabinosyl adenine
13. A pilot study of high‐dose 1‐β‐D‐arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology
14. Experimental hyperphenylalaninemia: dendritic alterations in cerebellum of rat
15. A form of familial degeneration of the cerebellum
16. Focal cerebral and cerebellar atrophy in a human subject due to organic mercury compounds
17. An experimental study of postmortem alterations in the granular cell layer of the cerebellar cortex
18. Neurotoxicity of antineoplastic drugs
19. High dose cytosine arabinoside in the treatment of patients with refractory acute non‐lymphocytic leukemia (abstract)
20. Production of injury to feline central nervous system with nucleic acid antimetabolite
21. Central nervous system toxicity of high‐dose systemic cytosine arabinoside
22. Tissue reactions in the gray matter of the central nervous system
23. Central and peripheral myelinopathy associated with systemic neoplasia and chemotherapy
24. Cerebellar cortical degeneration due to acute azide poisoning
25. Therapy of secondary acute nonlymphocytic leukemia with cytarabine
26. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy
27. Late cortical cerebellar atrophy: a form of hereditary cerebellar ataxia
28. High dose cytosine arabinoside in refractory acute leukemia
29. Paraplegia following intrathecal chemotherapy
30. Acute cerebellar dysfunction with high‐dose Ara‐C therapy
31. Cytosine arabinoside effects on developing cerebellum in tissue culture
32. Necrotising encephalopathy following instillation of methotrexate
33. Cytarabine and its effect on cerebellum of suckling mouse
34. Pharmacokinetics and metabolism of cytosine arabinoside in the central nervous system
35. A pathological study of Minamata disease in Japan
36. A restricted form of cerebellar degeneration occurring in alcoholic patients
37. The nutritional and metabolic diseases of the cerebellum: clinical and pathological aspects
38. Cerebello‐olivary degeneration: an example of heredo‐familial incidence
39. Neurotoxicity of commonly used antineoplastic agents
40. High dose cytosine arabinoside for the treatment of refractory acute leukemia (abstract)
41. Treatment of patients with refractory acute leukemia using intermediate and high dose cytosine arabinoside (abstract)
42. Cerebellar degeneration caused by high‐dose, systemic cytosine arabinoside (abstract)
43. Paraplegia following intrathecal cytosine arabinoside
44. Neurological complications of cancer chemotherapy